Treatment of glioblastoma cells with simvastatin or lovastatin also produced a consistent decrease in c-Myc, Mcl-1, Bcl-2, and Bcl-xL levels (Figure 6e,f,h,i,k,l, Supplementary Figure S2e,g,i). Here, MCL1 is linked to glioblastoma.